“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than any other area of the market,” acknowledges the author of today’s article. Given this, which small and mid-cap biotech stocks should do well this year? The author shares his picks, including some holdovers from 2020. For more, CLICK HERE.
Small- And Mid-Cap Biotech Picks For 2021
- by Alex Clarke